Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Submitted by
admin
on August 19, 2015 - 9:28am
Source:
Bidness, ETC
News Tags:
Amgen
romosozumab
osteoporosis
Headline:
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Do Not Allow Advertisers to Use My Personal information
